The Effect of Teriparatide Compared with Risedronate on Back Pain in Postmenopausal Women with Osteoporotic Vertebral Fractures

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-005258-29

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

to compare the efficacy of teriparatide 20 µg/day versus risedronate 35 mg/week on the reduction of back pain in postmenopausal women with prevalent osteoporotic vertebral fractures associated with chronic back pain.


Critère d'inclusion

  • chronic back pain and osteoporotic vertebral fracture(s)